 Home > Medical News > Latest Medical News > Wanchun Pharmaceutical's U.S. listing application for pranabulin was granted priority review by FDA

Wanchun Pharmaceutical's U.S. listing application for pranabulin was granted priority review by FDA

 Last Update: 2021-06-04
 Source: Internet
 Author: User

Tags

ilumya side effects

panc 1 cells

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

On June 1, Wanchun Medicine announced that its core product "Punablin Concentrate Solution for Injection" for use in chemotherapy-induced severe neutropenia (CIN) for new drug listing applications (NDA) has been officially accepted by the US FDA , And obtained the priority review qualification granted by the FDA.

Regardless of whether it is first-line or post-line treatment, chemotherapy is still an indispensable part of the current standard treatment plan for cancer.

Pranabrin is the First-In-Class Guanine Nucleotide Exchange Factor (GEF-H1) activator independently developed by Wanchun Pharmaceutical.

On November 16, Wanchun Medicine announced the international multi-center phase III study PROTECTIVE- of prenabrin combined with pegfilgrastim vs.

What’s more noteworthy is that as the world’s first immune small molecule drug that stimulates the maturation of dendritic cells, enhances antigen presentation, and activates T cells, punabulin is expected to become another blockbuster after PD-1/L1.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.